Spruce Biosciences, Inc.
SPRB
$0.0862
-$0.0436-33.59%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -53.04M | -39.43M | -43.11M | -46.75M | -47.92M |
| Total Depreciation and Amortization | 46.00K | 53.00K | 60.00K | 66.00K | 70.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.60M | 5.79M | 5.63M | 4.90M | 4.22M |
| Change in Net Operating Assets | -8.57M | -12.91M | -12.12M | 5.34M | 10.36M |
| Cash from Operations | -55.96M | -46.50M | -49.54M | -36.44M | -33.28M |
| Capital Expenditure | -- | 0.00 | -7.00K | -7.00K | -7.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 9.30M | 23.30M | 45.30M | 55.78M |
| Cash from Investing | -- | 9.30M | 23.29M | 45.29M | 55.78M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.62M | -1.62M | -1.62M | -1.62M | -1.62M |
| Issuance of Common Stock | 246.00K | 303.00K | 303.00K | 358.00K | 53.79M |
| Repurchase of Common Stock | -246.00K | -230.00K | -230.00K | -290.00K | -311.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | 0.00 | -62.00K | -2.72M |
| Cash from Financing | -1.62M | -1.55M | -1.55M | -1.62M | 49.14M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -57.59M | -38.75M | -27.80M | 7.23M | 71.64M |